CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,178,400 | -77.5% | 40,000 | -75.1% | 0.00% | -81.2% |
Q2 2023 | $5,232,248 | -57.9% | 160,400 | -40.9% | 0.02% | -61.9% |
Q4 2022 | $12,440,130 | +702.6% | 271,500 | +748.4% | 0.04% | +600.0% |
Q3 2022 | $1,550,000 | +101.0% | 32,000 | +63.0% | 0.01% | +100.0% |
Q2 2022 | $771,000 | -98.7% | 19,633 | -98.8% | 0.00% | -98.7% |
Q1 2022 | $59,728,000 | +48.0% | 1,622,600 | +83.3% | 0.24% | +47.2% |
Q4 2021 | $40,359,000 | +11.9% | 885,454 | -12.3% | 0.16% | +1.9% |
Q3 2021 | $36,072,000 | +456.6% | 1,009,300 | +208.2% | 0.16% | +444.8% |
Q2 2021 | $6,481,000 | -25.6% | 327,500 | -12.6% | 0.03% | -29.3% |
Q1 2021 | $8,713,000 | -64.0% | 374,600 | -67.9% | 0.04% | -65.3% |
Q4 2020 | $24,236,000 | -30.3% | 1,166,294 | -27.4% | 0.12% | -33.7% |
Q3 2020 | $34,777,000 | +349.5% | 1,606,350 | +389.3% | 0.18% | +256.0% |
Q2 2020 | $7,737,000 | -17.1% | 328,277 | -58.5% | 0.05% | -34.2% |
Q1 2020 | $9,328,000 | -71.0% | 791,200 | -73.9% | 0.08% | -55.0% |
Q4 2019 | $32,135,000 | +550.5% | 3,028,751 | +597.7% | 0.17% | +463.3% |
Q3 2019 | $4,940,000 | -27.7% | 434,100 | -28.5% | 0.03% | -16.7% |
Q2 2019 | $6,829,000 | – | 607,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |